Next Article in Journal
Intracellular Antibodies for Drug Discovery and as Drugs of the Future
Next Article in Special Issue
CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases
Previous Article in Journal
Safety, Tolerability, and Immunogenicity of V160, a Conditionally Replication-Defective Cytomegalovirus Vaccine, in Healthy Japanese Men in a Randomized, Controlled Phase 1 Study
Previous Article in Special Issue
Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine
 
 
Article

Article Versions Notes

Antibodies 2023, 12(1), 23; https://doi.org/10.3390/antib12010023
Action Date Notes Link
article xml file uploaded 13 March 2023 12:42 CET Original file -
article xml uploaded. 13 March 2023 12:42 CET Update -
article pdf uploaded. 13 March 2023 12:42 CET Version of Record https://www.mdpi.com/2073-4468/12/1/23/pdf-vor
article supplementary file uploaded. 13 March 2023 12:42 CET - https://www.mdpi.com/2073-4468/12/1/23#supplementary
article html file updated 13 March 2023 12:44 CET Original file -
article xml file uploaded 14 March 2023 03:05 CET Update -
article xml uploaded. 14 March 2023 03:05 CET Update https://www.mdpi.com/2073-4468/12/1/23/xml
article pdf uploaded. 14 March 2023 03:05 CET Updated version of record https://www.mdpi.com/2073-4468/12/1/23/pdf
article html file updated 14 March 2023 03:07 CET Update -
article html file updated 20 March 2023 22:54 CET Update https://www.mdpi.com/2073-4468/12/1/23/html
Back to TopTop